The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19

Not Applicable

• Conditions: Pneumonia, Viral; COVID
• Interventions: Device: Bedside lung ultrasound

• Registration Number: NCT04399681
• Lead Sponsor: Kanuni Sultan Suleyman Training and Research Hospital

Brief Summary

Novel Coronavirus 2019 Disease (COVID-19) mortality is highly associated with viral pneumonia and its complications. Accurate and prompt diagnosis shown to be effective to improve outcome by providing early treatment strategies. While chest X-ray (CXR) and computerized tomography (CT) are defined as gold standard, given the advantage of being an ionized radiation free, practical technique point of care ultrasound (POCUS) is also reported as a diagnostic tool for COVID-19. There are limited studies regarding the importance of POCUS in diagnosis and review of COVID-19. Therefore the aim of this study is to evaluate the utility of bedside lung ultrasound on diagnosis of COVID-19 for patients admitted to emergency department .

Detailed Description

Novel Coronavirus 2019 Disease (COVID-19) mortality is highly associated with viral pneumonia and its complications. Accurate and prompt diagnosis shown to be effective to improve outcome by providing early treatment strategies. While chest X-ray (CXR) and computerized tomography (CT) are defined as gold standard, given the advantage of being an ionized radiation free, practical technique point of care ultrasound (POCUS) is also reported as a diagnostic tool for COVID-19. There are limited studies regarding the importance of POCUS in diagnosis and review of COVID-19. Therefore the aim of this study is to evaluate the utility of bedside lung ultrasound on diagnosis of COVID-19 for patients admitted to emergency department .

Study Timeline

• Status Verified: 2020-05
• Study Start: 2020-05-10
• Study First Submitted: 2020-05-21
• Study First Submitted QC: 2020-05-21
• Last Update Submitted: 2020-05-21
• Study First Posted: 2020-05-22
• Last Update Posted: 2020-05-22
• Primary Completion: 2020-08-10
• Study Completion: 2020-09-10

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• All patients with an informed consent
• Admission to emergency department with symptoms or signs of COVID-19

Read More

Exclusion Criteria

• Absence of informed consent
• Patients under age of 18
• Presence of acute coronary syndrome
• Presence of chronic lung disease
• Pregnancy
• Presence of trauma
• Patients with a diagnosis of malignancy

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Suspected COVID-19 Group	Bedside lung ultrasound	Patients who admitted to emergency department with suspicion of COVID 19 pneumonia will be evaluated with POCUS/ bedside lung ultrasound.

Primary Outcome Measures

Name	Time	Method
Presence of viral pneumonia caused by COVID 19	3 months	Efficacy of POCUS on diagnosis of viral pneumonia caused by COVID 19

Trial Locations

Locations (1)

Istanbul Kanuni Sultan Suleyman Training and Research Hospital; 🇹🇷 Istanbul, Turkey